nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—CYP1A2—Imiquimod—skin cancer	0.171	0.196	CbGbCtD
Cinnarizine—CYP1A1—Dacarbazine—skin cancer	0.161	0.184	CbGbCtD
Cinnarizine—CYP2A6—Fluorouracil—skin cancer	0.11	0.127	CbGbCtD
Cinnarizine—CYP2C9—Vismodegib—skin cancer	0.107	0.123	CbGbCtD
Cinnarizine—CYP1A2—Vemurafenib—skin cancer	0.0937	0.108	CbGbCtD
Cinnarizine—CYP2D6—Vemurafenib—skin cancer	0.0772	0.0886	CbGbCtD
Cinnarizine—CYP1A2—Dacarbazine—skin cancer	0.0718	0.0824	CbGbCtD
Cinnarizine—CACNA1S—pes—skin cancer	0.044	0.38	CbGeAlD
Cinnarizine—CYP1A2—Fluorouracil—skin cancer	0.0421	0.0483	CbGbCtD
Cinnarizine—CYP2C9—Fluorouracil—skin cancer	0.0379	0.0435	CbGbCtD
Cinnarizine—CACNA1D—ear—skin cancer	0.0102	0.0877	CbGeAlD
Cinnarizine—HRH1—nose—skin cancer	0.00984	0.0849	CbGeAlD
Cinnarizine—CACNA1F—head—skin cancer	0.00513	0.0443	CbGeAlD
Cinnarizine—DRD2—nerve—skin cancer	0.00357	0.0308	CbGeAlD
Cinnarizine—CYP1A1—skin epidermis—skin cancer	0.00349	0.0301	CbGeAlD
Cinnarizine—CACNA1I—lymph node—skin cancer	0.00287	0.0248	CbGeAlD
Cinnarizine—CACNA1G—head—skin cancer	0.00281	0.0242	CbGeAlD
Cinnarizine—CACNA1C—connective tissue—skin cancer	0.00238	0.0205	CbGeAlD
Cinnarizine—CACNA1H—female reproductive system—skin cancer	0.0022	0.019	CbGeAlD
Cinnarizine—CYP1A2—nipple—skin cancer	0.00171	0.0148	CbGeAlD
Cinnarizine—CYP1A1—nipple—skin cancer	0.00169	0.0146	CbGeAlD
Cinnarizine—CACNA1C—female reproductive system—skin cancer	0.00168	0.0145	CbGeAlD
Cinnarizine—HRH1—nipple—skin cancer	0.0016	0.0138	CbGeAlD
Cinnarizine—CACNA1D—head—skin cancer	0.00152	0.0131	CbGeAlD
Cinnarizine—CACNA1C—head—skin cancer	0.0014	0.0121	CbGeAlD
Cinnarizine—CACNA1H—lymph node—skin cancer	0.00129	0.0111	CbGeAlD
Cinnarizine—CYP1A1—epithelium—skin cancer	0.00114	0.0098	CbGeAlD
Cinnarizine—HRH1—connective tissue—skin cancer	0.00114	0.0098	CbGeAlD
Cinnarizine—CYP1A1—skin of body—skin cancer	0.00108	0.00932	CbGeAlD
Cinnarizine—HRH1—epithelium—skin cancer	0.00108	0.0093	CbGeAlD
Cinnarizine—CACNA1D—lymph node—skin cancer	0.00106	0.00917	CbGeAlD
Cinnarizine—CYP2B6—skin of body—skin cancer	0.00105	0.00906	CbGeAlD
Cinnarizine—CYP1A1—mammalian vulva—skin cancer	0.000986	0.0085	CbGeAlD
Cinnarizine—CACNA1C—lymph node—skin cancer	0.000981	0.00846	CbGeAlD
Cinnarizine—HRH1—mammalian vulva—skin cancer	0.000935	0.00807	CbGeAlD
Cinnarizine—CYP2B6—lymphoid tissue—skin cancer	0.00085	0.00733	CbGeAlD
Cinnarizine—DRD2—head—skin cancer	0.000847	0.00731	CbGeAlD
Cinnarizine—CYP1A1—female reproductive system—skin cancer	0.000844	0.00728	CbGeAlD
Cinnarizine—CYP2B6—female reproductive system—skin cancer	0.00082	0.00707	CbGeAlD
Cinnarizine—CYP2C9—female reproductive system—skin cancer	0.000812	0.00701	CbGeAlD
Cinnarizine—HRH1—female reproductive system—skin cancer	0.000801	0.00691	CbGeAlD
Cinnarizine—CYP1A1—head—skin cancer	0.000705	0.00608	CbGeAlD
Cinnarizine—CYP2B6—head—skin cancer	0.000685	0.00591	CbGeAlD
Cinnarizine—HRH1—head—skin cancer	0.000669	0.00577	CbGeAlD
Cinnarizine—CYP2D6—female reproductive system—skin cancer	0.000609	0.00526	CbGeAlD
Cinnarizine—CYP2D6—head—skin cancer	0.000509	0.00439	CbGeAlD
Cinnarizine—CYP1A1—lymph node—skin cancer	0.000494	0.00426	CbGeAlD
Cinnarizine—HRH1—lymph node—skin cancer	0.000469	0.00404	CbGeAlD
Cinnarizine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—skin cancer	6.75e-05	0.00554	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—PTCH1—skin cancer	6.51e-05	0.00534	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—SMO—skin cancer	6.51e-05	0.00534	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—PTGER4—skin cancer	6.34e-05	0.0052	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—RASA1—skin cancer	6.24e-05	0.00512	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—RASA1—skin cancer	6.24e-05	0.00512	CbGpPWpGaD
Cinnarizine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—skin cancer	6.09e-05	0.00499	CbGpPWpGaD
Cinnarizine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—skin cancer	5.94e-05	0.00487	CbGpPWpGaD
Cinnarizine—CACNA1S—NCAM signaling for neurite out-growth—IL6—skin cancer	5.83e-05	0.00478	CbGpPWpGaD
Cinnarizine—CACNA1D—NCAM signaling for neurite out-growth—KRAS—skin cancer	5.81e-05	0.00477	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	5.71e-05	0.00468	CbGpPWpGaD
Cinnarizine—CACNA1S—Alzheimers Disease—TP53—skin cancer	5.65e-05	0.00463	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	5.6e-05	0.0046	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—MC1R—skin cancer	5.44e-05	0.00447	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—PTCH2—skin cancer	5.15e-05	0.00422	CbGpPWpGaD
Cinnarizine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—skin cancer	5.11e-05	0.00419	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—RASA1—skin cancer	5.07e-05	0.00416	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—PTCH2—skin cancer	5.06e-05	0.00415	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—CDK4—skin cancer	5.05e-05	0.00415	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—MC1R—skin cancer	4.94e-05	0.00406	CbGpPWpGaD
Cinnarizine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—skin cancer	4.94e-05	0.00405	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	4.89e-05	0.00401	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	4.8e-05	0.00394	CbGpPWpGaD
Cinnarizine—CACNA1D—NCAM signaling for neurite out-growth—IL6—skin cancer	4.73e-05	0.00388	CbGpPWpGaD
Cinnarizine—CACNA1D—Alzheimers Disease—TP53—skin cancer	4.58e-05	0.00376	CbGpPWpGaD
Cinnarizine—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	4.54e-05	0.00373	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—RASA1—skin cancer	4.45e-05	0.00365	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	4.36e-05	0.00358	CbGpPWpGaD
Cinnarizine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—skin cancer	4.34e-05	0.00356	CbGpPWpGaD
Cinnarizine—CACNA1C—NCAM signaling for neurite out-growth—IL6—skin cancer	4.16e-05	0.00341	CbGpPWpGaD
Cinnarizine—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	4.08e-05	0.00335	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—PTCH2—skin cancer	4.04e-05	0.00331	CbGpPWpGaD
Cinnarizine—CACNA1C—Alzheimers Disease—TP53—skin cancer	4.03e-05	0.0033	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—NRAS—skin cancer	3.94e-05	0.00323	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	3.75e-05	0.00308	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—CDK4—skin cancer	3.73e-05	0.00306	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—MC1R—skin cancer	3.72e-05	0.00305	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—PLIN2—skin cancer	3.7e-05	0.00304	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	3.69e-05	0.00302	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—MC1R—skin cancer	3.66e-05	0.003	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—CDK4—skin cancer	3.61e-05	0.00296	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—PTGER4—skin cancer	3.58e-05	0.00294	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—SHH—skin cancer	3.52e-05	0.00289	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	3.39e-05	0.00278	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—KRAS—skin cancer	3.39e-05	0.00278	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—SMO—skin cancer	3.34e-05	0.00274	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—PTCH1—skin cancer	3.34e-05	0.00274	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—PLIN2—skin cancer	3.25e-05	0.00267	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—PTGER4—skin cancer	3.25e-05	0.00267	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	3.22e-05	0.00264	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—RHOU—skin cancer	3.2e-05	0.00262	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	3.16e-05	0.00259	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—RHOU—skin cancer	3.14e-05	0.00257	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—CDK4—skin cancer	3.06e-05	0.00251	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—GLI2—skin cancer	3.06e-05	0.00251	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.06e-05	0.00251	CbGpPWpGaD
Cinnarizine—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	3.04e-05	0.0025	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CSPG4—skin cancer	2.98e-05	0.00245	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—MC1R—skin cancer	2.92e-05	0.0024	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.92e-05	0.0024	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—NRAS—skin cancer	2.9e-05	0.00238	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—HRAS—skin cancer	2.88e-05	0.00236	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—GLI1—skin cancer	2.88e-05	0.00236	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—NRAS—skin cancer	2.81e-05	0.00231	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—NRAS—skin cancer	2.81e-05	0.00231	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	2.78e-05	0.00228	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—IL6—skin cancer	2.76e-05	0.00226	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—SUFU—skin cancer	2.73e-05	0.00224	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—SHH—skin cancer	2.65e-05	0.00218	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—PTCH2—skin cancer	2.64e-05	0.00217	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CSPG4—skin cancer	2.62e-05	0.00215	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—SHH—skin cancer	2.61e-05	0.00214	CbGpPWpGaD
Cinnarizine—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	2.6e-05	0.00213	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—PTCH2—skin cancer	2.6e-05	0.00213	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—PTCH1—skin cancer	2.52e-05	0.00206	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—SMO—skin cancer	2.52e-05	0.00206	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—KRAS—skin cancer	2.5e-05	0.00205	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—CDK4—skin cancer	2.49e-05	0.00204	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.48e-05	0.00204	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—PTCH1—skin cancer	2.47e-05	0.00203	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—SMO—skin cancer	2.47e-05	0.00203	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—PTGER4—skin cancer	2.45e-05	0.00201	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—KRAS—skin cancer	2.42e-05	0.00199	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—CDK4—skin cancer	2.42e-05	0.00198	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—KRAS—skin cancer	2.42e-05	0.00198	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—PTGER4—skin cancer	2.4e-05	0.00197	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—NRAS—skin cancer	2.39e-05	0.00196	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.28e-05	0.00187	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—CDK4—skin cancer	2.18e-05	0.00179	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.16e-05	0.00177	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—HRAS—skin cancer	2.12e-05	0.00174	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—MC1R—skin cancer	2.1e-05	0.00173	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—SHH—skin cancer	2.08e-05	0.00171	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—NRAS—skin cancer	2.07e-05	0.0017	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—RASA1—skin cancer	2.07e-05	0.0017	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—MC1R—skin cancer	2.07e-05	0.00169	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—HRAS—skin cancer	2.06e-05	0.00169	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—HRAS—skin cancer	2.06e-05	0.00169	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—KRAS—skin cancer	2.05e-05	0.00168	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—IL6—skin cancer	2.03e-05	0.00167	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—ENO2—skin cancer	2.03e-05	0.00166	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—NRAS—skin cancer	2.01e-05	0.00165	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—SMO—skin cancer	1.97e-05	0.00162	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—PTCH1—skin cancer	1.97e-05	0.00162	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—IL6—skin cancer	1.97e-05	0.00161	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—IL6—skin cancer	1.97e-05	0.00161	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.95e-05	0.0016	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—NRAS—skin cancer	1.94e-05	0.00159	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—PTGER4—skin cancer	1.92e-05	0.00158	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—MC1R—skin cancer	1.91e-05	0.00157	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—MC1R—skin cancer	1.88e-05	0.00154	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.86e-05	0.00153	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—PLIN2—skin cancer	1.83e-05	0.0015	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—KRAS—skin cancer	1.78e-05	0.00146	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—ENO2—skin cancer	1.78e-05	0.00146	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—HRAS—skin cancer	1.75e-05	0.00143	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—KRAS—skin cancer	1.73e-05	0.00142	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—NRAS—skin cancer	1.7e-05	0.0014	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—NRAS—skin cancer	1.7e-05	0.0014	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—FOXO4—skin cancer	1.7e-05	0.00139	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—IL6—skin cancer	1.67e-05	0.00137	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—KRAS—skin cancer	1.67e-05	0.00137	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.58e-05	0.0013	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PTCH2—skin cancer	1.56e-05	0.00128	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PTCH2—skin cancer	1.53e-05	0.00126	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—HRAS—skin cancer	1.52e-05	0.00124	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PLIN2—skin cancer	1.47e-05	0.00121	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CSPG4—skin cancer	1.47e-05	0.00121	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—HRAS—skin cancer	1.47e-05	0.0012	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—KRAS—skin cancer	1.47e-05	0.0012	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—KRAS—skin cancer	1.47e-05	0.0012	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—IL6—skin cancer	1.45e-05	0.00119	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—HRAS—skin cancer	1.42e-05	0.00116	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—IL6—skin cancer	1.41e-05	0.00115	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—PTGER4—skin cancer	1.38e-05	0.00113	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—NRAS—skin cancer	1.38e-05	0.00113	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—SHH—skin cancer	1.36e-05	0.00112	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PLIN2—skin cancer	1.36e-05	0.00112	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—PTGER4—skin cancer	1.36e-05	0.00111	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—IL6—skin cancer	1.36e-05	0.00111	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—SHH—skin cancer	1.34e-05	0.0011	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—PTCH1—skin cancer	1.29e-05	0.00106	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—SMO—skin cancer	1.29e-05	0.00106	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—PTCH1—skin cancer	1.27e-05	0.00104	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—SMO—skin cancer	1.27e-05	0.00104	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—PTGER4—skin cancer	1.26e-05	0.00103	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	1.25e-05	0.00103	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—HRAS—skin cancer	1.25e-05	0.00102	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—HRAS—skin cancer	1.25e-05	0.00102	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—PTGER4—skin cancer	1.23e-05	0.00101	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—NRAS—skin cancer	1.21e-05	0.000996	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—IL6—skin cancer	1.19e-05	0.000978	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—IL6—skin cancer	1.19e-05	0.000978	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—KRAS—skin cancer	1.19e-05	0.000976	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CSPG4—skin cancer	1.19e-05	0.000974	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—GLI2—skin cancer	1.18e-05	0.000971	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—ERCC2—skin cancer	1.18e-05	0.000967	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—GLI2—skin cancer	1.16e-05	0.000953	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TERT—skin cancer	1.13e-05	0.000929	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—MC1R—skin cancer	1.13e-05	0.000926	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—GLI1—skin cancer	1.11e-05	0.000913	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—MC1R—skin cancer	1.11e-05	0.000909	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CSPG4—skin cancer	1.1e-05	0.0009	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—GLI1—skin cancer	1.09e-05	0.000896	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	1.08e-05	0.000884	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SUFU—skin cancer	1.05e-05	0.000865	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—KRAS—skin cancer	1.05e-05	0.000857	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SUFU—skin cancer	1.04e-05	0.000849	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—ERCC2—skin cancer	1.04e-05	0.000849	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—TP53—skin cancer	1.03e-05	0.000844	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PLIN2—skin cancer	1.02e-05	0.00084	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PLIN2—skin cancer	1.02e-05	0.000833	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—HRAS—skin cancer	1.01e-05	0.000829	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—ENO2—skin cancer	1e-05	0.000821	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—IL6—skin cancer	9.68e-06	0.000794	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—NRAS—skin cancer	9.55e-06	0.000783	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—IL6—skin cancer	9.42e-06	0.000773	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	9.16e-06	0.000751	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—BRAF—skin cancer	8.97e-06	0.000736	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—HRAS—skin cancer	8.89e-06	0.000729	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	8.77e-06	0.000719	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PLIN2—skin cancer	8.68e-06	0.000712	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—IL6—skin cancer	8.51e-06	0.000698	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CSPG4—skin cancer	8.26e-06	0.000677	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—KRAS—skin cancer	8.22e-06	0.000674	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CSPG4—skin cancer	8.18e-06	0.000671	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—ENO2—skin cancer	8.07e-06	0.000662	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SHH—skin cancer	8.04e-06	0.00066	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—RASA1—skin cancer	7.99e-06	0.000656	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SHH—skin cancer	7.9e-06	0.000648	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—RASA1—skin cancer	7.85e-06	0.000644	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SMO—skin cancer	7.63e-06	0.000625	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PTCH1—skin cancer	7.63e-06	0.000625	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PTCH1—skin cancer	7.49e-06	0.000614	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SMO—skin cancer	7.49e-06	0.000614	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—ENO2—skin cancer	7.46e-06	0.000611	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PTGER4—skin cancer	7.42e-06	0.000609	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PTGER4—skin cancer	7.29e-06	0.000598	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—PTGS2—skin cancer	7.07e-06	0.00058	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CSPG4—skin cancer	6.99e-06	0.000574	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HRAS—skin cancer	6.98e-06	0.000573	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—IL6—skin cancer	6.68e-06	0.000548	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—FOXO4—skin cancer	6.56e-06	0.000538	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—FOXO4—skin cancer	6.44e-06	0.000528	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—PTGS2—skin cancer	6.21e-06	0.000509	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.83e-06	0.000478	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—ERCC2—skin cancer	5.81e-06	0.000477	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—NRAS—skin cancer	5.64e-06	0.000463	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—ENO2—skin cancer	5.61e-06	0.00046	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—ENO2—skin cancer	5.56e-06	0.000456	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—KRAS—skin cancer	4.85e-06	0.000398	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—ENO2—skin cancer	4.75e-06	0.00039	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—ERCC2—skin cancer	4.69e-06	0.000385	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TERT—skin cancer	4.38e-06	0.000359	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.35e-06	0.000357	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—ERCC2—skin cancer	4.33e-06	0.000355	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TP53—skin cancer	4.31e-06	0.000354	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TERT—skin cancer	4.3e-06	0.000353	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HRAS—skin cancer	4.13e-06	0.000338	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—IL6—skin cancer	3.95e-06	0.000324	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.72e-06	0.000305	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—NRAS—skin cancer	3.69e-06	0.000303	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—NRAS—skin cancer	3.62e-06	0.000297	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—PTGS2—skin cancer	3.49e-06	0.000286	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—BRAF—skin cancer	3.47e-06	0.000284	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—BRAF—skin cancer	3.41e-06	0.000279	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—ERCC2—skin cancer	3.26e-06	0.000267	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—ERCC2—skin cancer	3.23e-06	0.000265	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—KRAS—skin cancer	3.18e-06	0.00026	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—KRAS—skin cancer	3.12e-06	0.000256	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PTGS2—skin cancer	2.81e-06	0.000231	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—ERCC2—skin cancer	2.76e-06	0.000226	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HRAS—skin cancer	2.7e-06	0.000221	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HRAS—skin cancer	2.65e-06	0.000217	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PTGS2—skin cancer	2.6e-06	0.000213	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—IL6—skin cancer	2.58e-06	0.000212	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—IL6—skin cancer	2.54e-06	0.000208	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—NRAS—skin cancer	2.18e-06	0.000179	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—NRAS—skin cancer	2.14e-06	0.000176	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PTGS2—skin cancer	1.95e-06	0.00016	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PTGS2—skin cancer	1.94e-06	0.000159	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—KRAS—skin cancer	1.88e-06	0.000154	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—KRAS—skin cancer	1.84e-06	0.000151	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TP53—skin cancer	1.67e-06	0.000137	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PTGS2—skin cancer	1.66e-06	0.000136	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TP53—skin cancer	1.64e-06	0.000134	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HRAS—skin cancer	1.59e-06	0.000131	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HRAS—skin cancer	1.57e-06	0.000128	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—IL6—skin cancer	1.53e-06	0.000125	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—IL6—skin cancer	1.5e-06	0.000123	CbGpPWpGaD
